Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Brent Babcock Discusses New CRISPR IP Alliance

December 19, 2016  | Brenton R. Babcock

Partner Brent Babcock, Chair of the firm’s USPTO Trials & Post-Grant Proceedings group, was quoted in “Some Consensus in the CRISPR Patent Case,” an article published in MedCity News. The article discuses four companies founded in the CRISPR space that announced last Friday, December 16, that they had formed an IP alliance.

Read the article here

 

Related Links

Industries

News & Insights

Blog - Biotechnology
Jul 2025
FDA Announces Review of New Clinical Trials That Export Americans’ Biological Samples to Hostile Countries
On June 18, 2025, the U.S. Food and Drug Administration (FDA) announced that it will review new clinical trials that involve sending biological samples to “hostile countries,” to prevent exploitation...
Blog - Biotechnology
Jul 2025
CRISPR Dispute Heats Up With Recent Federal Court Decision
On May 12, 2025, the U.S. Court of Appeals for the Federal Circuit (CAFC) revived the Regents of the University of California’s (Regents) challenge to the Broad Institute’s CRISPR-Cas9 patents,...
News
Jul 2025
Tom Cowan Discusses Growth in Aerospace Industry Investment with The Space Report
Speaking with aerospace industry publication The Space Report, partner Tom Cowan shared his perspective on the state of investment in the space sector across startups and mature companies. In the...